Static Chart APTOCROM Inc.

Stocks

End-of-day quote Korea S.E. 2026-10-20			5-day change	1st Jan Change
1,853.00 ^KRW	+0.60%		-3.54%	-62.94%

09-22	Aprogen Medicines Inc. announced that it has received KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc.	CI
09-03	Aprogen Medicines Inc. announced that it expects to receive KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc.	CI

Duration

Period